Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In
Source: SeekingAlpha
2025-06-18 12:29:51 ET
Topline Summary and Update
Read the full article on Seeking Alpha
For further details see:
Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In
Nuvectis Pharma Inc.
NASDAQ: NVCT
NVCT Trading
-1.0% G/L:
$8.95 Last:
10,312 Volume:
$9.10 Open:
NVCT Latest News
February 11, 2026 07:30:00 am
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
NVCT Stock Data
$223,874,191
14,667,089
29.18%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Fort Lee
